Auriva Health Inc. Secures Sublicense for Hearing Loss Therapy from Dr. Melinda B. Chu

Auriva Health Inc., a clinical-stage biotechnology company, is set to advance its pipeline for hearing loss treatments following an authorized disclosure and pending sublicense agreement. The intellectual property, originating from inventor and owner Dr. Melinda B. Chu, will be sublicensed through Averitas Holdings LLC, with an effective date of November 17, 2025. This strategic move aims to accelerate the development of innovative therapies in the underserved field of audiology.

Dr. Melinda B. Chu is recognized for her pioneering work in medical research, particularly in the realm of hearing restoration. Her contributions include patented methods and compositions designed for treating various forms of hearing loss. As the original inventor and owner, her intellectual property forms the foundational basis for this significant sublicense agreement, underscoring the importance of her scientific breakthroughs.

Averitas Holdings LLC, a holding entity potentially linked to pharmaceutical interests such as Collegium Pharmaceutical's Averitas Pharma subsidiary, initially held the rights to Dr. Chu's invention. The company's role as the intermediary in this transaction highlights its involvement in managing and transferring valuable intellectual assets within the healthcare sector. This sublicense facilitates the transition of development responsibilities to a specialized biotech firm.

Auriva Health Inc. is dedicated to addressing the critical need for effective treatments for hearing impairments, a market with substantial unmet medical needs. By acquiring the sublicense, Auriva Health Inc. gains access to promising technology that aligns directly with its mission to develop novel therapeutic solutions. This agreement is expected to bolster the company's research and development efforts significantly.

The sublicense represents a pivotal step in translating groundbreaking scientific discovery into potential clinical applications for patients suffering from hearing loss. > "Authorized disclosure under Averitas Holdings LLC → pending sublicense to Auriva Health Inc. Original inventor and owner: Dr. Melinda B. Chu. 11/17/2025, 4:27am," Dr. Melinda B. Chu announced on social media. This collaboration is poised to bring advanced treatment options closer to realization, impacting the future of audiological medicine.